|
MORE DETAILS
|
AFTERNOON WORKSHOP - 13 March 2012 - LONDON
|
Patient = Customer? Healthcare = FMCG?
This will be a highly interactive discussion and workshop, using the IML keypads.
Topics to be addressed include: How the patient can and should impact drug development and healthcare delivery. The growing importance of the patient in shaping scientific and medical research, involvement in panels for discussion and decision making. Obvious parallels to the FMCG industry. The need for Pharma, health services, and public sector to be more "Patient Intelligent" and to understand and act on specific patient needs and requirements. History and experience of patient involvement in the public sector, guidelines and lessons learned, implications and current activities in the Pharmaceutical sector. Development of models for incorporation of patient perspectives and experiences in healthcare outcomes.
Useful reading:
Uhm S, Liabo K, Stewart R, Rees R, Oliver S. Patient and public perspectives shaping scientific and medical research: panels for data, discussions, and decisions. Patient Intelligence 2012;4:1-10 [Read article here]
Van Dongen, N. Become 'patient intelligent' to cure treatment aversion. Pharmaceutical Marketing Europe; January 2012 [Read article here]
Date: 13 March 2012
Venue: Computershare offices, Vintner's Place, 68 Upper Thames Street, London, EC4V 3BJ [DIRECTIONS]
Time: Arrive anytime from 12.00 onwards for a light buffet lunch. The presentations will start promptly at 13.00 and finish by 16.00 with a break mid-way for afternoon tea and coffee.
WHO IS COMING?
035 Lee Forster, InterPhase Consulting
034 Richard Kenyon, Independent
033 Steve Subhanshu, Medipin Interactive Systems
032 Elif Fincanci-Smith, Darwin Healthcare Communications
031 Amanda Halliday, Independent
030 Clare Birkbeck, Independent
029 Jonathan Fairley, De Facto Communications
028 Tim Mustill, InterPhase Consulting
027 Emily Menzies, Solaris Health
026 Abigail Brown, Solaris Health
025 Amber Fensome, ApotheCom
024 Jill Goodier, ApotheCom
023 Daniel Baldwin, Mash Health
022 Jo Cullum, Mash Health
021 Magdaline Chu, BioScience Communications
020 Gemma Williams, BioScience Communications
019 Jessica Beishon, PAREXEL MMS
018 Peneli Oliver, Independent
017 Felicity Murdoch, AXON
016 Jane Lamprill, Independent
015 Lisa Lovelidge, Independent
014 Philippa Flemming, Aspire Scientific
013 Stuart Brill, Media Contacts
012 Jonathan Tulip, Omega Scientific
011 Loretta Flockhart, Omega Scientific
010 Amandeep Dhoot, Omega Scientific
009 Alison Chisholm, Optimum Patient Care
008 Mark Pownall, inScience Communications
007 Corinne Swainger, Independent
006 Emma Thorp, RBW Consulting
005 Katherine Biglen, RBW Consulting
004 Jan Seal-Roberts, Wolters Kluwer Pharma Solutions
003 Jane Tricker, Independent
002 Kevin Toale, Dove Press
001 Peter Llewellyn, NetworkPharma
To make sure you're included in announcements about future events just email Peter Llewellyn, if you haven't already done so, to register your interest.
|
|
SPONSORED BY:
|
Dove Press
IML
Presentations by:
Mark Nuijten
Founding member and Managing Director Europe at Minerva - International Health Economic Network
[More biographical
details]
Professor Sandy Oliver
Social Science Research Unit and EPPI-Centre and Institute of Education, University of London
Nadine van Dongen
Managing Director / Founder PIP Patient Intelligence Panel
[More biographical
details]
|
|
